GlassScriptPhysician profile
Jessica E Batson
NPI 1194968727
$2,963.92
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,007 · 2022: $981 · 2023: $494 · 2024: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.38 | 2021-2024 | |
| Novo Nordisk INC | $375.06 | 2021-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $150.93 | 2021-2024 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $148.42 | 2021-2023 | Shingrix |
| Eisai INC. | $144.27 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.46 | 2022-2024 | |
| Abiomed | $140.42 | 2022 | |
| Globus Medical, INC. | $106.02 | 2022-2023 | Coalition Agx / Agx Rp |
| Astrazeneca Pharmaceuticals LP | $106.02 | 2021-2024 | Breztri |
| Boston Scientific Corporation | $101.53 | 2021-2024 | Watchman Flx, Watchman Access System |
| Takeda Pharmaceuticals U.S.A., INC. | $91.33 | 2021-2023 | Trintellix |
| Novartis Pharmaceuticals Corporation | $87.30 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $86.11 | 2021-2022 | |
| Amgen INC. | $84.36 | 2021-2024 | Repatha |
| Otsuka America Pharmaceutical, INC. | $76.68 | 2021-2024 | Rexulti |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.73 | 2021-2024 | Trulance, Xifaxan |
| Exact Sciences Corporation | $62.67 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $61.74 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $55.36 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.72 | 2021 | |
| Corcept Therapeutics | $42.27 | 2024 | Korlym |
| Paratek Pharmaceuticals, INC. | $37.41 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.01 | 2022 | |
| Adlon Therapeutics L.P. | $25.65 | 2021 | |
| Radius Health, INC. | $23.73 | 2022 | |
| Tolmar, INC. | $20.37 | 2023 | |
| Pfizer INC. | $18.82 | 2023 | |
| Merck Sharp & Dohme LLC | $16.69 | 2022 | |
| Currax Pharmaceuticals LLC | $15.94 | 2023 | Contrave |
| Sanofi-Aventis U.S. LLC | $14.02 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.71 | 2021 | |
| Antares Pharma, INC. | $13.56 | 2024 | Xyosted |
| Dexcom, INC. | $13.50 | 2021 | |
| Tris Pharma INC | $13.38 | 2023 | Dyanavel Xr |
| Sunovion Pharmaceuticals INC. | $13.33 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.13 | 2023 | Quviviq |
| Bausch Health US, LLC | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Batson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.